Patents Assigned to Medicare Pharmaceuticals Inc.
  • COMPOSITION FOR INHIBITING GROWTH OF SARS-COV-2 AND METHOD OF PREPARING THE SAME
    Publication number: 20220119381
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 21, 2022
    Applicants: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun NA, Kyung Pyo KANG, Jin Hwan JUN, Geon GO, Hyeon Jun NA, Sang Jin KANG, Young Hyun NA, Se Jin YOON, Su Ji NA
  • Composition for inhibiting growth of SARS-CoV-2 and method of preparing the same
    Patent number: 11292789
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 5, 2022
    Assignees: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun Na, Kyung Pyo Kang, Jin Hwan Jun, Geon Go, Hyeon Jun Na, Sang Jin Kang, Young Hyun Na, Se Jin Yoon, Su Ji Na
  • Composition for preventing or treating metabolic diseases containing artemisiae capillaris herba and citrus unshiu peel complex extracts as active ingredients
    Patent number: 11285188
    Abstract: The present disclosure relates to a composition for preventing or treating metabolic diseases, the composition containing Artemisiae capillaris Herba and Citrus unshiu Peel complex extracts as active ingredients. Specifically, in the Artemisiae capillaris Herba and Citrus unshiu Peel complex extracts according to the present disclosure, the content of ingredients useful for prevention of metabolic diseases including obesity is much higher than in extracts obtained only from Artemisiae capillaris Herba. In addition, when a high-fat diet mouse model is administered the complex extracts, the levels of total cholesterol, LDL, and triglycerides in the blood are reduced. Accordingly, the complex extracts of the present disclosure may be used as a composition or functional material for preventing or treating metabolic diseases including obesity, hyperlipidemia, and hypercholesterolemia.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: March 29, 2022
    Assignee: Medicare Pharmaceuticals Inc.
    Inventors: Do Hyun Na, Jin Hwan Jun, Kyung Pyo Kang
  • COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING ARTEMISIAE CAPILLARIS HERBA AND CITRUS UNSHIU PEEL COMPLEX EXTRACTS AS ACTIVE INGREDIENTS
    Publication number: 20200171113
    Abstract: The present disclosure relates to a composition for preventing or treating metabolic diseases, the composition containing Artemisiae capillaris Herba and Citrus unshiu Peel complex extracts as active ingredients. Specifically, in the Artemisiae capillaris Herba and Citrus unshiu Peel complex extracts according to the present disclosure, the content of ingredients useful for prevention of metabolic diseases including obesity is much higher than in extracts obtained only from Artemisiae capillaris Herba. In addition, when a high-fat diet mouse model is administered the complex extracts, the levels of total cholesterol, LDL, and triglycerides in the blood are reduced. Accordingly, the complex extracts of the present disclosure may be used as a composition or functional material for preventing or treating metabolic diseases including obesity, hyperlipidemia, and hypercholesterolemia.
    Type: Application
    Filed: November 7, 2019
    Publication date: June 4, 2020
    Applicant: Medicare Pharmaceuticals Inc.
    Inventors: Do Hyun NA, Jin Hwan JUN, Kyung Pyo KANG